Additionally, IFI30 knockdown upregulated HRAS expression in ESCC cells, activated the c‐Jun N‐terminal kinase (JNK) signaling pathway, and increased the expression of P16 and P21. This evidence concerns the gene HRAS and esophageal squamous cell carcinoma.